Aurealis Therapeutics Novel Chronic Wound Treatment to be Presented at the 4th Experts Meeting on Microbiome & Skin Health and Disease on December 15th, 2020

Basel Switzerland, Kuopio Finland – December 15th, 2020.

Haritha Samaranayake, MD, PhD, Medical Director of Aurealis Therapeutics will give a talk about development of AUP16, the company´s lead product for non-healing wounds such as diabetic foot ulcer. The presentation is titled “Development of a Live Biotherapeutic to treat diabetic foot ulcer“ and is scheduled for Tuesday, December 15^th, 2020 at 14:30 CET.

More information about the event can be found here:

https://www.baseclear.com/experts-meetings/4th-microbiome-skin-health-and-disease/

For more information about Aurealis Therapeutics and AUP16, please contact:

Juha Yrjänheikki, CEO                                                                                                                              Email: juha(at)aurealistherapeutics.com